Tamsulosin Hydrochloride 0.4 mg (Tablet in Capsule) + Deflazacort 30 mg *(Tablet in Capsule Technology)* Capsule | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Tamsulosin Hydrochloride 0.4 mg (Tablet in Capsule) + Deflazacort 30 mg *(Tablet in Capsule Technology)* Capsule
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Capsule
Class: Alpha-1A blocker + corticosteroid combination
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Tamsulosin Hydrochloride 0.4 mg (Tablet in Capsule) + Deflazacort 30 mg *(Tablet in Capsule Technology)* Capsule Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Tamsulosin Hydrochloride 0.4 mg (Tablet in Capsule) + Deflazacort 30 mg *(Tablet in Capsule Technology)* Capsule brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Tamsulosin Hydrochloride 0.4 mg (Tablet in Capsule) + Deflazacort 30 mg *(Tablet in Capsule Technology)* Capsule is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Tamsulosin Hydrochloride 0.4 mg (Tablet in Capsule) + Deflazacort 30 mg *(Tablet in Capsule Technology)* formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Medical expulsive therapy for lower-ureteric stones (5–10 mm) with mucosal oedema
- Symptomatic relief in benign prostatic hyperplasia with inflammatory component
- Post-stenting ureteric symptoms (specialist use)
Mechanism of Action
Tamsulosin selectively blocks alpha-1A adrenoceptors which dominate in the prostate, bladder neck and distal ureter — relaxing smooth muscle and easing voiding. Deflazacort is a glucocorticoid prodrug converted to its active 21-OH metabolite; it suppresses phospholipase A2, reducing prostaglandin and leukotriene production and shrinking oedema around the impacted stone — improving stone passage rates in MET.
Dosage & Administration
- Adults: 1 capsule once daily, 30 minutes after the same meal each day
- Continue for 4 weeks or until stone expulsion
- Swallow whole — do not crush or chew
- Use under urologist supervision
Side Effects
- Postural hypotension and dizziness
- Ejaculatory dysfunction
- Fluid retention
- Increased appetite
- Mood changes (with steroid component)
- Hyperglycaemia in diabetics
Contraindications
- Hypersensitivity to tamsulosin or deflazacort
- History of orthostatic hypotension
- Severe hepatic impairment
- Untreated active infection
- Live vaccines during treatment
Storage
Store below 30 °C in a dry place, protected from light and moisture.
PCD Pharma Franchise for Tamsulosin Hydrochloride 0.4 mg (Tablet in Capsule) + Deflazacort 30 mg *(Tablet in Capsule Technology)* Capsule
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 1 x 10 (Blister)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Tamsulosin Hydrochloride 0.4 mg (Tablet in Capsule) + Deflazacort 30 mg *(Tablet in Capsule Technology)* Capsule — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Tamsulosin Hydrochloride 0.4 mg (Tablet in Capsule) + Deflazacort 30 mg *(Tablet in Capsule Technology)* Capsule, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Tamsulosin Hydrochloride 0.4 mg (Tablet in Capsule) + Deflazacort 30 mg *(Tablet in Capsule Technology)* Capsule?
Trumac Healthcare is a WHO-GMP certified manufacturer of Tamsulosin Hydrochloride 0.4 mg (Tablet in Capsule) + Deflazacort 30 mg *(Tablet in Capsule Technology)* Capsule in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Tamsulosin Hydrochloride 0.4 mg (Tablet in Capsule) + Deflazacort 30 mg *(Tablet in Capsule Technology)* Capsule available for PCD pharma franchise on monopoly basis?
Yes. We offer Tamsulosin Hydrochloride 0.4 mg (Tablet in Capsule) + Deflazacort 30 mg *(Tablet in Capsule Technology)* Capsule for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Tamsulosin Hydrochloride 0.4 mg (Tablet in Capsule) + Deflazacort 30 mg *(Tablet in Capsule Technology)* Capsule?
Available pack sizes include: 10 x 1 x 10 (Blister).
What is the MRP / trade price for Tamsulosin Hydrochloride 0.4 mg (Tablet in Capsule) + Deflazacort 30 mg *(Tablet in Capsule Technology)* Capsule?
MRPs range from ₹6900 to ₹6900 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Tamsulosin Hydrochloride 0.4 mg (Tablet in Capsule) + Deflazacort 30 mg *(Tablet in Capsule Technology)* Capsule?